GLP-1

money cash coins dollars

Biotech

Metsera follows phase 1 weight loss data with $215M series B

Metsera is riding the wave of continued enthusiasm for GLP-1 drugs and its own early-stage data to bring in a hefty $215 million series B fundraise.

James Waldron Nov 13, 2024 9:15am

AstraZeneca still 'playing to win' in obesity, execs say

Nov 4, 2024 11:49am

Graphic of two hands shaking under a red and purple light

In $285M deal, Novo taps Ascendis to help create monthly GLP-1

Nov 4, 2024 8:43am

viking ship long boat chase race water sunset

Viking oral obesity med posts 6.8% weight loss for highest dose

Nov 4, 2024 7:30am

raised boxing glove with confetti falling around it

Chinese insulin maker’s GLP-1 bests Ozempic in ph. 2, company says

Oct 15, 2024 11:12am

finance numbers tape money

Kailera launches with $400M series A, 4 Chinese obesity drugs

Oct 1, 2024 8:30am